RFP
Closing Date:

Platform Technologies Related to Oncology, Rare Genetic and Haematological Disease, and Medicinal Chemistry

Platform Technologies Related to Oncology, Rare Genetic and Haematological Disease, and Medicinal Chemistry
https://stock.adobe.com/uk/209283409

Takeda Pharmaceutical are launching an open innovation initiative inviting researchers to submit their proposals addressing emerging technological platforms related to oncology, rare genetic or haematological disease, or medicinal chemistry. One‑year projects will be funded up to JPY 5,000,000 or equivalent amount, including indirect costs.

Projects should address one of four areas:

REF#6 Translational research platforms for immuno-oncology. Specifically: (i) translationally-relevant humanised animal models and/or in vitro/ex vivo tumour organoid systems...

To see the full details and submit your response please register now

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile

Responses:

  • Applicants must use the submission template when preparing a response outlining a research project proposal

Essential information:

Submission form:

Register Now

Share this call with professional partners:

An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.